Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
New platform allows organizations to launch branded, privacy-first savings challenges for customers, employees, ...
She left her National Cancer Institute job in January, she said, because the “work is no longer based on facts or truth.” After President Donald Trump returned to office, Chou said, health ...
WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration ...
Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...
If only a small fraction of what we know about sugar’s effects were known about any other food additive, that substance would be banned.” Pure, White and Deadly by John Yudkin.
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.
The Daily Pour on MSN
Q&A: Meet David Nutt, the professor who ranked every drug by societal harm — and put alcohol first
Named by the Evening Standard as one of the top 100 people shaping London in 2025, Professor David Nutt has authored over 500 research papers and more than 30 books. One of the world’s foremost ...
American Heart Association argues that South Carolina bill H.4303 would benefit the tobacco industry at the expense of public ...
Harry Potter actor Daniel Radcliffe has been open about his struggle with alcohol and tobacco addiction. Here is how the human body repairs itself from damage, and how you can take inspiration from ...
As millions begin using weight-loss drugs, a new question is surfacing online and in medical discussions: could these medications also influence romantic desire or intimacy?
A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was associated with lower risks of developing substance use disorders compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results